Medical Imaging and Diagnostic Ontology

Last uploaded: April 25, 2022
Preferred Name

adverse effect

Synonyms
Definitions

The OAE official website is: http://www.oae-ontology.org/.

ID

http://purl.obolibrary.org/obo/OAE_0000001

comment

The OAE official website is: http://www.oae-ontology.org/.

alternative term

adverse reaction

AE

Definition

a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event.

A drug adverse effect is a response to a drug that is noxious and unintended and occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for modifi-cation of physiological function.

definition source

WEB: http://www.ncbi.nlm.nih.gov/pubmed/25093068

WEB: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm

WEB: http://en.wikipedia.org/wiki/Adverse_event

WHO. (1972). International drug monitoring: the role of national centres. Thechnical Report Services WHO, no 498

editor note

YH: The current term 'adverse event' is different from the term definition shown in our paper: He Y, Xiang Z, Sarntivijai S, Toldo L, Ceusters W. OAE: a realism-based biomedical ontology for the representation of adverse events. Adverse Event Representation Workshop, International Conference on Biomedical Ontologies (ICBO), University at Buffalo, NY, July 26-30, 2011. Full lenghth conference proceeding paper. We made the name changing in order to make OAE cover the broader sense of the 'adverse event' which does not assume definite causal effect between an adverse event and a medical intervention. In current definition, the adverse event emphasizes the time association and assumes a likelihood of such a causal association. This term 'adverse event' is stil under the OGMS:pathological bodily process. The 'adverse event' defined in the above paper has now been changed to a new term: 'causal adverse event'. See more information in the new publication: Yongqun He Y, Sirarat Sarntivijai, Yu Lin, Zuoshuang Xiang, Abra Guo, Shelley Zhang, Desikan Jagannathan, Luca Toldo, Cui Tao and Barry Smith. OAE: The Ontology of Adverse Events. Journal of Biomedical Semantics. 2014, 5:29 doi:10.1186/2041-1480-5-29. PMID: 25093068.PMCID: PMC4120740.

YH: The main scope of OAE includes: (1) represent terms and relations in the area of adverse events, (2) assess possible associations between an adverse event and a medical intervention, particularly, identify any causal effect of a medical intervention to an adverse event; and (2) understand the mechanism (including molecular mechanisms) of causal adverse events.

YH: An adverse event is possibly induced by the medical intervention. It can be caused by the medical intervention, or may not be caused by the medical intervention. One ultimate goal (or the goal in clinics) of study adverse events is to assess if the adverse event outcome is due to the medical intervention.

YH: In development of OAE, we initially use vaccine adverse event as our use case. A vaccine adverse event is associated with a vaccination (i.e. a medical intervention), regardless of whether it is considered vaccine-related, and includes any side effect, injury, toxicity, or sensitivity reaction or significant failure of immunization (i.e., a pharmacologic action). Ref: Baylor NW and Midthum K. Regulation and testing of vaccines. In: Vaccines (Editors: Plotkin S, Orenstein W, and Offit P). 2008. p1623.

YH: There has been discussion regarding whether the term 'side effect' is an alternative term for 'adverse event'. In AERO, the term 'AERO:adverse event' represents a subset of those adverse events for which causality has been established. In OAE, an adverse event for which causality has been established is called 'causal adverse event'.

YH: An adverse event is a process that has specified output of some adverse medical outcome (e.g., symptom, sign or accident) after a medical intervention (or process) (e.g., administration of drug or vaccine). The medical intervention can be an administration of a drug, a vaccine (i.e., vaccination), or a special nutritional product (for example, dietary supplement, infant formula, medical food), surgery, or usage of a medical device.

Melanie Courtot and YH: More work is needed on how to restrict the scope of a term to be an 'adverse event', notably regarding temporal association. When is an appropirate time interval between a medical intervention and an adverse event observed? One week, one month, one year, or a lifetime? For some well-studied medical interventions (e.g., administration of many vaccines or drugs), we probably have a general idea. For many new interventions, we don't know much. In OAE, this issue is associated with defining the 'adverse event incubation time'.

label

adverse event

adverse effect

maps to

http://purl.obofoundry.org/obo/DINTO_000038

prefixIRI

obo1:OAE_0000001

prefLabel

adverse effect

term editor

Yongqun He

subClassOf

http://purl.obolibrary.org/obo/BFO_0000016

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/OAE_0000001 VO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 ENM SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OAE SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 PDRO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 EUPATH SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 CTO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 VICO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 INBANCIDO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OVAE SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OCMR SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 DINTO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OPMI SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 COVID-19 SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 EPIO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OLAM SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 GSSO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 ODAE SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 CIDO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OCVDAE SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 DOVES SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 ICO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 KTAO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 MELO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 DIDEO SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 ODNAE SAME_URI
http://purl.obolibrary.org/obo/OAE_0000001 OGSF SAME_URI
http://www.ebi.ac.uk/efo/EFO_0009658 EFO LOOM
http://www.semanticweb.org/hx-jta/ontologies/thyroid_cancer_ontology#Adverse_Effect TCO LOOM
http://purl.obolibrary.org/obo/OAE_0000001 DINTO LOOM
http://purl.obolibrary.org/obo/OAE_0001000 OAE LOOM
http://www.stanford.edu/~coulet/phare.owl#DrugAdverseReaction PHARE LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#52060 OCHV LOOM